CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 51 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,618,000 | -26.8% | 545,973 | -28.1% | 0.00% | -50.0% |
| Q3 2016 | $7,674,000 | -4.0% | 759,002 | +6.6% | 0.00% | 0.0% |
| Q2 2016 | $7,996,000 | -14.8% | 712,064 | +3.6% | 0.00% | 0.0% |
| Q1 2016 | $9,385,000 | -26.3% | 687,035 | +2.3% | 0.00% | -33.3% |
| Q4 2015 | $12,735,000 | -5.3% | 671,334 | -6.3% | 0.00% | 0.0% |
| Q3 2015 | $13,447,000 | +31.1% | 716,418 | +4.0% | 0.00% | +50.0% |
| Q2 2015 | $10,259,000 | +171.3% | 688,981 | +176.0% | 0.00% | +100.0% |
| Q1 2015 | $3,781,000 | +21.9% | 249,650 | +7.2% | 0.00% | 0.0% |
| Q4 2014 | $3,102,000 | +1208.9% | 232,904 | +1139.8% | 0.00% | – |
| Q3 2014 | $237,000 | +16.7% | 18,786 | -6.8% | 0.00% | – |
| Q2 2014 | $203,000 | -91.7% | 20,146 | -89.0% | 0.00% | -100.0% |
| Q1 2014 | $2,457,000 | – | 182,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,013,039 | $8,955,000 | 1.12% |
| INGALLS & SNYDER LLC | 1,455,812 | $12,869,000 | 0.87% |
| RA Capital Management | 1,858,474 | $16,429,000 | 0.52% |
| Perceptive Advisors | 2,150,641 | $19,549,000 | 0.51% |
| Alambic Investment Management, L.P. | 17,900 | $158,000 | 0.38% |
| KENNEDY CAPITAL MANAGEMENT LLC | 260,362 | $2,302,000 | 0.08% |
| Spark Investment Management LLC | 17,500 | $154,000 | 0.08% |
| Alyeska Investment Group, L.P. | 451,900 | $3,995,000 | 0.08% |
| Windsor Creek Advisors, LLC | 13,621 | $120,000 | 0.04% |
| Connor, Clark & Lunn Investment Management Ltd. | 364,544 | $3,223,000 | 0.03% |